• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AMS SPECTRA CONCEALABLE PENILE PROSTHESIS; PROSTHESIS PENILE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AMS SPECTRA CONCEALABLE PENILE PROSTHESIS; PROSTHESIS PENILE Back to Search Results
Model Number 720054-01
Device Problem Mechanical Problem (1384)
Patient Problem Complaint, Ill-Defined (2331)
Event Date 06/19/2019
Event Type  Injury  
Event Description
It was reported that there is a system failure of the spectra penile prosthesis (spp) device and because the "implant deflected." it was further reported the system failure was the patient's "inability to end a sexual intercourse." the patient's penis was deflection to the left side due to the prosthesis.It is planned that the that the revision will be performed on (b)(6) 2019.It was also further reported that the spp was explanted and a new 16 cm ambicor penile prosthesis (app) device was implanted.The outcome of the surgery was successful.The patient is under observation until the implant is activated.
 
Event Description
It was reported that there is a system failure of the spectra penile prosthesis (spp) device and because the implant deflected.It was further reported the system failure was the patient's inability to end a sexual intercourse.The patient's penis was deflection to the left side due to the prosthesis.It is planned that the that the revision will be performed on (b)(6) 2019.It was also further reported that the spp was explanted and a new 16cm ambicor penile prosthesis (app) device was implanted.The outcome of the surgery was successful.The patient is under observation until the implant is activated.
 
Manufacturer Narrative
Malfunction was reported.The spectra cylinders were visually inspected and functionally tested.One cylinder performed within specifications.One cylinder had a hole in the outer layer that was the result of tool damage consistent with explant damage.This cylinder was functional.Review of manufacturing documentation was performed to ensure that all required in-process and final inspections and testing were completed.Review of the manufacturing records found no evidence that the device failed to meet applicable product specifications prior to shipment from bsc.The investigation conclusion code of no problem detected was chosen as the reported device problem could not be confirmed.The event cannot be reproduced or substantiated; therefore, no escalation to ncep, capa, or scar is required.If further information is received at a later date, the product investigation will be reopened to address the additional information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMS SPECTRA CONCEALABLE PENILE PROSTHESIS
Type of Device
PROSTHESIS PENILE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
10700 bren road w
minnetonka MN 55343
MDR Report Key8799182
MDR Text Key151330250
Report Number2183959-2019-65077
Device Sequence Number1
Product Code FAE
UDI-Device Identifier00878953005201
UDI-Public00878953005201
Combination Product (y/n)N
PMA/PMN Number
K090663
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 09/30/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date11/12/2020
Device Model Number720054-01
Device Catalogue Number720054-01
Device Lot Number0111592003
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/07/2019
Initial Date Manufacturer Received 06/26/2019
Initial Date FDA Received07/17/2019
Supplement Dates Manufacturer Received09/26/2019
Supplement Dates FDA Received09/30/2019
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age72 YR
-
-